pharma · Chronic Spontaneous Urticaria · Asthma
Novartis India
Novartis Pharmaceuticals
Novartis Pharmaceuticals is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Spontaneous Urticaria, Asthma, Systemic Lupus Erythematosus, Breast Cancer, Multiple Sclerosis. NovaP
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Founded
- 1996
- Employees
- 2,240
- Programs
- 341
- Drugs
- 317
- Patents
- 0
Blood draw for Lp(a)
Unknown · other · Cardiovascular Disease and Lipoprotein(a)
Blood draw for Lp(a) for Cardiovascular Disease and Lipoprotein(a) is a Unknown program (other) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code CTQJ230A12001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Novartis Pharmaceuticals
- Phase
- Unknown
- Modality
- other
- Indication
- Cardiovascular Disease and Lipoprotein(a)
- Status
- completed
- Trials
- 1